Philippe Gervois

4.9k total citations · 1 hit paper
38 papers, 4.2k citations indexed

About

Philippe Gervois is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Philippe Gervois has authored 38 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Epidemiology and 13 papers in Physiology. Recurrent topics in Philippe Gervois's work include Peroxisome Proliferator-Activated Receptors (28 papers), Adipose Tissue and Metabolism (13 papers) and Adipokines, Inflammation, and Metabolic Diseases (12 papers). Philippe Gervois is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (28 papers), Adipose Tissue and Metabolism (13 papers) and Adipokines, Inflammation, and Metabolic Diseases (12 papers). Philippe Gervois collaborates with scholars based in France, United States and Russia. Philippe Gervois's co-authors include Bart Staels, Jean‐Charles Fruchart, Inès Pineda‐Torra, Ngoc Vu‐Dac, Philippe Delerive, Teake Kooistra, P. Hans, Robert Kleemann, Philippe Poulain and Bruno Derudas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Philippe Gervois

38 papers receiving 4.1k citations

Hit Papers

Peroxisome Proliferator-a... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Gervois France 27 2.6k 1.1k 929 849 627 38 4.2k
Bingbing Jiang United States 29 2.6k 1.0× 1.4k 1.3× 1.1k 1.2× 705 0.8× 701 1.1× 42 4.9k
Todd Leff United States 36 2.5k 0.9× 1.3k 1.2× 648 0.7× 768 0.9× 634 1.0× 57 4.2k
Kathleen K. Brown United States 20 2.1k 0.8× 1.0k 1.0× 951 1.0× 862 1.0× 529 0.8× 27 4.0k
Ming-Hui Zou United States 31 2.3k 0.9× 1.3k 1.2× 987 1.1× 749 0.9× 616 1.0× 38 4.8k
Xiuyun Hou United States 22 2.5k 1.0× 1.4k 1.3× 1.1k 1.2× 786 0.9× 796 1.3× 26 4.7k
Shanqin Xu United States 25 2.2k 0.8× 1.5k 1.4× 1.1k 1.2× 708 0.8× 755 1.2× 38 4.6k
Anne‐Marie Lefebvre France 19 3.5k 1.3× 1.6k 1.5× 919 1.0× 511 0.6× 504 0.8× 47 4.7k
Michael Schupp Germany 34 2.6k 1.0× 1.5k 1.4× 920 1.0× 481 0.6× 828 1.3× 66 4.8k
Régis Saladin France 21 2.6k 1.0× 1.9k 1.8× 1.2k 1.3× 717 0.8× 578 0.9× 25 5.2k
Mengwei Zang United States 30 3.3k 1.3× 1.6k 1.5× 1.7k 1.9× 986 1.2× 1.1k 1.7× 42 6.1k

Countries citing papers authored by Philippe Gervois

Since Specialization
Citations

This map shows the geographic impact of Philippe Gervois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Gervois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Gervois more than expected).

Fields of papers citing papers by Philippe Gervois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Gervois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Gervois. The network helps show where Philippe Gervois may publish in the future.

Co-authorship network of co-authors of Philippe Gervois

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Gervois. A scholar is included among the top collaborators of Philippe Gervois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Gervois. Philippe Gervois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gervois, Philippe, et al.. (2023). Gut–Joint Axis: Impact of Bifidobacterial Cell Wall Lipoproteins on Arthritis Development. Nutrients. 15(23). 4861–4861. 1 indexed citations
2.
Waterlot, Christophe, Emmanuelle Lipka, Philippe Gervois, et al.. (2021). Ecocatalysed Hurtley reaction: Synthesis of urolithin derivatives as new potential RAGE antagonists with anti-ageing properties. Sustainable Chemistry and Pharmacy. 23. 100518–100518. 10 indexed citations
3.
Gervois, Philippe & Roxane Mansouri. (2012). PPARα as a therapeutic target in inflammation-associated diseases. Expert Opinion on Therapeutic Targets. 16(11). 1113–1125. 46 indexed citations
4.
Renault, Nicolas, Amaury Farce, Jamal El Bakali, et al.. (2012). Virtual Screening of CB2 Receptor Agonists from Bayesian Network and High‐Throughput Docking: Structural Insights into Agonist‐Modulated GPCR Features. Chemical Biology & Drug Design. 81(4). 442–454. 19 indexed citations
5.
Fontaine, Coralie, Elena Rigamonti, Atsushi Nohara, et al.. (2007). Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human Macrophages. Circulation Research. 101(1). 40–49. 106 indexed citations
7.
Chauvet, Caroline, Brigitte Bois-Joyeux, Coralie Fontaine, et al.. (2005). The Gene Encoding Fibrinogen-β Is a Target for Retinoic Acid Receptor-Related Orphan Receptor α. Molecular Endocrinology. 19(10). 2517–2526. 13 indexed citations
8.
Genoux, Annelise, Philippe Gervois, Corinne Rommens, et al.. (2004). Apolipoprotein A5 is an inflammatory responsive gene down-regulated by tumor necrosis factor alpha and interleukin-1. Lawrence Berkeley National Laboratory. 3 indexed citations
9.
Gervois, Philippe, J C Fruchart, & Bart Staels. (2004). Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists. International Journal of Clinical Practice. 58(143). 22–29. 38 indexed citations
10.
Gervois, Philippe, Robert Kleemann, Antoine Pilon, et al.. (2004). Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate. Journal of Biological Chemistry. 279(16). 16154–16160. 180 indexed citations
11.
Gervois, Philippe & Jean‐Charles Fruchart. (2003). PPARγ : un récepteur nucléaire majeur de l’adipogenèse. médecine/sciences. 19(1). 20–22. 3 indexed citations
12.
Fontaine, Coralie, Guillaume Dubois, Yannick Duguay, et al.. (2003). The Orphan Nuclear Receptor Rev-Erbα Is a Peroxisome Proliferator-activated Receptor (PPAR) γ Target Gene and Promotes PPARγ-induced Adipocyte Differentiation. Journal of Biological Chemistry. 278(39). 37672–37680. 205 indexed citations
13.
Gervois, Philippe, Ngoc Vu‐Dac, Robert Kleemann, et al.. (2001). Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β. Journal of Biological Chemistry. 276(36). 33471–33477. 134 indexed citations
14.
Guerre-Millo, Michèle, Philippe Gervois, Eric Raspé, et al.. (2000). PPARa activators improve insulin sensitivity and reduce adiposity. Journal of Biological Chemistry. 93 indexed citations
15.
Gervois, Philippe, Jean‐Charles Fruchart, Philippe Delerive, & Bart Staels. (2000). Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators. Journal of Biological Chemistry. 275(47). 36703–36707. 411 indexed citations
16.
Raspé, Eric, Hélène Duez, Philippe Gervois, et al.. (1999). Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor Rev-erba.. Circulation. 1 indexed citations
17.
Gervois, Philippe, Guillaume Dubois, V. P. Kosykh, et al.. (1999). Fibrates Increase Human REV-ERBα Expression in Liver via a Novel Peroxisome Proliferator-Activated Receptor Response Element. Molecular Endocrinology. 13(3). 400–409. 132 indexed citations
18.
Pineda‐Torra, Inès, Philippe Gervois, & Bart Staels. (1999). Peroxisome proliterator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Current Opinion in Lipidology. 10(2). 151–160. 190 indexed citations
19.
Vu‐Dac, Ngoc, Philippe Gervois, Jean‐Charles Fruchart, et al.. (1998). Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.. Journal of Clinical Investigation. 102(3). 625–632. 114 indexed citations
20.
Vu‐Dac, Ngoc, Philippe Gervois, Thilo Grötzinger, et al.. (1997). Transcriptional Regulation of Apolipoprotein A-I Gene Expression by the Nuclear Receptor RORα. Journal of Biological Chemistry. 272(36). 22401–22404. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026